DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

DAIC

JULY 9, 2024

The American Heart Association, commemorating its 100th year, has announced its volunteer leadership for fiscal year 2024-2025, which includes Keith Churchwell, MD, FAHA, a cardiologist renowned as a health equity champion, and Marsha Jones, an executive leader in workplace diversity and inclusion. Keith Churchwell, M.D.,

Innovation 111

Innovation Health Disparities Cardiovascular Disease Medicaid 111

DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept. On Thursday, Sept.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

HCPLive

OCTOBER 4, 2024

This episode focuses on 5 key updates from Maui Derm NP+PA Fall 2024 in Nashville. Counting down the most impactful news at major medical meetings, it’s the HCPLive Five!

98

98

HCPLive

OCTOBER 23, 2024

Jonathan Barratt, PhD, discusses his excitement surrounding data and programming at the American Society of Nephrology's Kidney Week 2024, with a focus on IgAN.

105

105

HCPLive

DECEMBER 16, 2024

In this episode, hosts reflect on the advancement in CGM that reshaped care for diabetes and overall health during 2024.

Diabetes 81

Diabetes 81

HCPLive

NOVEMBER 10, 2024

PEDFIC data at NASPGHAN 2024 show mild, transient diarrhea events with odevixibat for cholestatic pruritus in PFIC, resolving in most cases.

Pediatrics 98

Pediatrics 98

HCPLive

OCTOBER 4, 2024

A review of 5 highly anticipated FDA decisions expected by year-end, including acoramidis for ATTR-CM, olezarsen for FCS, sotagliflozin for T1D and CKD, and more.

116

116

HCPLive

DECEMBER 9, 2024

In this month's episode of Lungcast, Jacob Sands, MD, discusses the American Lung Associations recently newly-released 2024 State of Lung Cancer report.

Cancer 76

Cancer 76

HCPLive

DECEMBER 16, 2024

Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.

Critical Care 78

Critical Care 78

The New England Journal of Medicine

DECEMBER 4, 2024

A 22-year-old woman with headache and fever was transferred to the ICU for respiratory failure. Head CT was notable for acute subarachnoid hemorrhage; transthoracic and transesophageal echocardiography was also performed (shown in a video). A diagnosis was made.

ICU 75

ICU Hemorrhage 75

HCPLive

OCTOBER 26, 2024

Neuen, Wadhwani, and Barratt discuss atacicept promise in IgA nephropathy based on phase 2b ORIGIN OLE results, at-home use, and the future of kidney disease care.

Kidney Disease 83

Kidney Disease 83

Cardiometabolic Health Congress

DECEMBER 17, 2024

Cardiovascular and renal health are undeniably linkedwhen one system is compromised, the other is often at risk. For healthcare providers, adopting an integrated, patient-centered approach is important for better outcomes. Here are our five top tips to help you stay aligned with the latest guidelines and improve cardiorenal care.

Kidney Disease 52

Kidney Disease CME Research Education 52

HCPLive

DECEMBER 20, 2024

Yehuda Handelsman, MD reflects on the WCIRDC 2024s comprehensive approach to advancing cardiometabolic care through multidisciplinary collaboration.

52

52

American Heart News - Heart News

JUNE 4, 2024

ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in risk factors including high blood pressure and obesity, total costs related to. Embargoed until 4 a.m.

Risk Factors 143

Risk Factors Cardiovascular Disease Blood Pressure Obesity 143

HCPLive

MARCH 7, 2024

On March 07, 2024, Boehringer Ingelheim announced it would be instituting a $35 per month out-of-pocket cost cap for its portfolio of inhaler products, with this cap going into effect on June 01, 2024.

140

140

American Heart News - Heart News

FEBRUARY 12, 2024

12, 2024 DALLAS, Feb. 12, 2024 — Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of lives in the 100 years since the founding in 1924 of the American. Embargoed until 4 a.m. ET Monday, Feb.

Cardiovascular Disease 138

Cardiovascular Disease 138

HCPLive

MARCH 20, 2024

announced the FDA's approval of aprocitentan (Tryvio) for treatment-resistant hypertension on March 20, 2024. Idorsia Ltd.

Hypertension 145

Hypertension 145

HCPLive

JULY 31, 2024

Trust in physicians and hospitals dropped from over 70% in 2020 to under 50% in 2024, with declines seen across all demographics, a new survey shows.

COVID-19 140

COVID-19 Hospital 140

American Heart News - Heart News

JANUARY 31, 2024

1, 2024 – From news desks to iconic buildings, scores of people and landmarks across the U.S. DALLAS, Feb. will once again “go red” on National Wear Red Day, Feb. 2, to raise awareness that cardiovascular disease is the No. 1 killer of women and support.

Cardiovascular Disease 144

Cardiovascular Disease 144

American Heart News - Heart News

MARCH 1, 2024

DALLAS, March 1, 2024 – Losing an extra hour of sleep may not be the worst thing that could happen when you “spring forward” at the start of daylight saving time. According to the American Heart Association, celebrating one hundred years of lifesaving.

142

142

American Heart News - Heart News

JANUARY 24, 2024

24, 2024 — In an effort to identify effective food is medicine approaches for incorporating healthy food into health care delivery, the American Heart Association, the world’s leading voluntary organization focused on heart and brain health. DALLAS, Jan.

Research 136

Research 136

Nature Reviews - Cardiology

JANUARY 29, 2024

Nature Reviews Cardiology, Published online: 30 January 2024; doi:10.1038/s41569-024-00990-7 In this Comment, we critically examine the association between the increasing consumption of ultra-processed foods and their negative effect on cardiovascular health.

Cardiovascular Disease 144

Cardiovascular Disease Public Health 144

American Heart News - Heart News

JANUARY 9, 2024

9, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods could help treat heart disease, a genetics expert from Pennsylvania exploring the molecular mechanisms of lipid metabolism and. DALLAS, Jan.

Heart Disease 133

Heart Disease Research 133

American Heart News - Stroke News

JANUARY 29, 2024

DALLAS, January 29, 2024 — A new scientific statement from the American Heart Association emphasizes the need to increase patients’ and physicians’ awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate.

Risk Factors 134

Risk Factors Thrombosis Stroke Strokes 134

American Heart News - Heart News

JANUARY 11, 2024

11, 2024 — Weather forecasters may call it ‘white fluffy stuff,’ however, snow can be a bigger danger than many people may realize. DALLAS, Jan. According to the American Heart Association, celebrating its Centennial birthday as the world’s leading.

133

133

American Heart News - Heart News

JUNE 20, 2024

DALLAS, June 20, 2024 — It’s only the first day of summer and record high temperatures are already being reported across much of the U.S. That’s prompted the American Heart Association, celebrating a century of lifesaving service as the world’s leading.

134

134

Nature Reviews - Cardiology

JANUARY 1, 2024

Nature Reviews Cardiology, Published online: 02 January 2024; doi:10.1038/s41569-023-00962-3 Cardiovascular autonomic dysfunction (CVAD) is a malfunction of the autonomic control of circulatory homeostasis and is an important component of post-COVID-19 syndrome.

COVID-19 145

COVID-19 Tachycardia 145

Nature Reviews - Cardiology

JANUARY 3, 2024

Nature Reviews Cardiology, Published online: 04 January 2024; doi:10.1038/s41569-023-00979-8 In this Review, Sarraju and Nissen summarize the clinical trial evidence for coronary atherosclerotic plaque stabilization and regression with plasma LDL-cholesterol-lowering therapy and other treatments.

Plaque 139

Plaque Cholesterol 139

HCPLive

NOVEMBER 21, 2024

Ahmad Masri, MD, MS, discusses a study from AHA 2024 detailing changing risk profiles and outcomes in trials among patients with ATTR-CM.

Outcomes 125

Outcomes 125

Nature Reviews - Cardiology

JANUARY 1, 2024

Nature Reviews Cardiology, Published online: 02 January 2024; doi:10.1038/s41569-023-00958-z In this Review, the authors discuss the latest insights on RNA-binding proteins and RNA biology and appraise them in the context of cardiovascular research, summarizing the progress in our understanding of the involvement of RNA-binding proteins in cardiac (..)

Research 138

Research 138

HCPLive

JUNE 14, 2024

These findings, presented at RAD 2024, highlight risk of atopic dermatitis patients for developing various cancers as well as major adverse cardiovascular events.

Cancer 124

Cancer 124

Becker's Hospital Review - Cardiology

JULY 23, 2024

News' 2024-2025 ranking, evaluating nearly 800 hospitals for challenging heart and vascular Discover the top heart hospitals in every state according to U.S.

Hospital 124

Hospital 124

HCPLive

DECEMBER 9, 2024

Pipe discussed findings from the open-label extension of the ATLAS studies at ASH 2024.

105

105

HCPLive

MARCH 8, 2024

On March 08, 2024, the FDA approved semaglutide 2.4 mg (Wegovy) to reduce cardiovascular risk in adults with obesity or overweight and heart disease based on the SELECT trial.

Obesity 124

Obesity Heart Disease 124

American Heart News - Heart News

JUNE 13, 2024

DALLAS, June 13, 2024 — The American Heart Association, through its Center for Health Technology and Innovation (the Center), has selected five companies to participate in the American Heart Association Heart and Brain Health Accelerator.

Technology 127

Technology Innovation 127

American Heart News - Heart News

APRIL 22, 2024

DALLAS, April 22, 2024 — More Black and Hispanic people in the U.S. feel confident performing Cardiopulmonary Resuscitation (CPR). A 2023 American Heart Association survey found that 44% of Black Americans now feel confident in performing.

126

126